Literature DB >> 16092805

Herbal medicine and cancer: an introductory overview.

Jonathan Treasure1.   

Abstract

OBJECTIVES: To present Western herbal medicine from the perspective of a "food" model of herbs in contrast to the pharmaceutical "drug" model derived from mainstream medicine. Historical, political, and regulatory aspects of herbal medicine in the United States; core principles of herbal medicine in terms of the natural link between food and medicine; dietary chemopreventive plant compounds in the form of herbal medicines; and herb-drug interactions are briefly discussed, with an emphasis on beneficial interactions with conventional chemotherapy. DATA SOURCES: Literature on dietary chemopreventive compounds; phytotherapeutic training and clinical practice.
CONCLUSION: Botanical medicine, based on dietary chemopreventive compounds plays an important role in integrative cancer treatment. IMPLICATIONS FOR NURSING PRACTICE: Knowledge of the differences between herbal and conventional medicine in terms of a food, medicine, and poison model will help nurses facilitate patient decision-making choices in integrative cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092805     DOI: 10.1016/j.soncn.2005.04.006

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  22 in total

Review 1.  Herbal medicine as inducers of apoptosis in cancer treatment.

Authors:  Elham Safarzadeh; Siamak Sandoghchian Shotorbani; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

3.  Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.

Authors:  Deep Kwatra; Anand Venugopal; David Standing; Sivapriya Ponnurangam; Animesh Dhar; Ashim Mitra; Shrikant Anant
Journal:  J Pharm Sci       Date:  2013-10-15       Impact factor: 3.534

4.  Antitumor and antimetastatic effects of licochalcone A in mouse models.

Authors:  Jin-Kyung Kim; Eun Kyung Shin; Jun Hong Park; Yoon Hee Kim; Jung Han Yoon Park
Journal:  J Mol Med (Berl)       Date:  2010-04-11       Impact factor: 4.599

5.  In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula [see text] with cisplatin in non-small cell lung cancer.

Authors:  Xu-ming Ji; Bing Ouyang; Heng Liu; Guo-wei Liu; Zhi-chun Wu; Hua-yun Yu; Chun-yan Wang; Zhong-xia Wang; Wen-ping Wang
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

6.  Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation.

Authors:  Kaouther Kolli-Bouhafs; Abdelaziz Boukhari; Abdurazzag Abusnina; Emilie Velot; Jean-Pierre Gies; Claire Lugnier; Philippe Rondé
Journal:  Invest New Drugs       Date:  2011-12-15       Impact factor: 3.850

7.  Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.

Authors:  Ke-Wang Sun; Ying-Yu Ma; Tian-Pei Guan; Ying-Jie Xia; Chang-Ming Shao; Le-Gao Chen; Ya-Jun Ren; Hai-Bo Yao; Qiong Yang; Xu-Jun He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.

Authors:  Sara M Johnson; Xiaofu Wang; B Mark Evers
Journal:  J Surg Res       Date:  2009-08-05       Impact factor: 2.192

Review 9.  On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies.

Authors:  Roja Rahimi; Shilan Mozaffari; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

10.  Curcumin nanomedicine: a road to cancer therapeutics.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.